Milnacipran
Back to searchMolecule Structure
Scientific Name
Milnacipran
Description of the Drug
Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for the treatment of fibromyalgia and a short-term treatment of major depressive disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04896
http://www.drugbank.ca/drugs/DB04896
Brand Name(s)
Not Available
Company Owner(s)
Allergan Sales Llc, Amneal Pharmaceuticals, Uspharma Windlas Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL114034 | ||
Human Metabolome Database | HMDB0254055 | ||
DrugBank | DB04896 | ||
PubChem: Thomson Pharma | 16725872 | ||
PubChem | 11622909 | ||
LINCS | LSM-45870 | ||
BindingDB | 50490618 | ||
DrugCentral | 1808 | ||
Guide to Pharmacology | 7436 | ||
rxnorm | MILNACIPRAN HYDROCHLORIDE | SAVELLA | MILNACIPRAN |
ChEBI | 135005 |